American Airlines Group (NASDAQ:AAL), a provider of air transportation services for passengers and cargo, closed at $13.55, down 7.00%. Shares fell after fourth-quarter results missed profit expectations and management detailed shutdown and storm-related pressures. Investors are watching 2026 guidance for stronger earnings and revenue growth. Trading volume reached 100.9 million shares, about 82% above its three-month average of 55.5 million shares. American Airlines Group IPO'd in 2005 and has fallen 30% s ...

First Trust Capital Strength ETF (FTCS) is a large, US-listed exchange-traded fund with a market capitalization of $8 billion. The fund targets companies with robust balance sheets and strong market positions, aiming to deliver stability and long-term growth potential. Its disciplined index-based approach and diversified holdings provide investors with exposure to high-quality equities while maintaining a focus on capital strength.Underlying holdings primarily consist of common stocks and REITs, with at lea ...

Core Insights - Certara, Inc. operates in the healthcare information services sector, focusing on biosimulation and regulatory expertise to enhance drug development processes [1] - The company's shares are currently priced at $8.74, reflecting an 18% decline over the past year, significantly underperforming the S&P 500 by 34.5 percentage points [2] Company Performance - Certara's stock experienced a sharp decline of approximately 23% following its latest earnings report, which was interpreted as a reset of expectations rather than a fundamental business failure [5] - The company reported a 10% year-over-year revenue growth in the third quarter, with software revenue increasing by 22%, and it returned to positive net income while raising its full-year profitability outlook [5] Investment Activity - Kopion Asset Management acquired an additional 327,064 shares of Certara, valued at approximately $3.37 million, during the quarter ending December 31, indicating confidence in the company's long-term prospects [3][4] - The value of Kopion's position in Certara increased by $645,681 over the quarter, reflecting both new purchases and positive price movement [4] Market Position - Certara's biosimulation software and regulatory services are integral to drug development workflows, characterized by high switching costs and persistent demand, even in tighter budget environments [6] - The company operates in a defensible niche within the pharmaceutical R&D technology market, which may provide resilience against market fluctuations [6]

Core Insights - Apollo Global Management's stock increased by 7% following quarterly results that surpassed Wall Street expectations [1] - Fee-related earnings rose by 23% to $652 million, exceeding the forecast of $626.5 million by approximately 4% [1] - Adjusted net income reached $1.35 billion, or $2.17 per share, which is 14% higher than the consensus estimate of $1.90 [1] Capital Inflows and Assets Under Management - The firm experienced capital inflows of $82 billion in the quarter and $219 billion over the past 12 months, marking a 24% year-over-year increase [2] - Total assets under management climbed to $908 billion, approaching the $1 trillion milestone, with $21 billion attributed to the acquisition of Bridge Investment Group [2] Insurance Unit Performance - Apollo's Athene insurance unit reported $871 million in spread-related earnings, the highest in two years, contributing to significant new loans of approximately $75 billion during the quarter [4] - The merger with Athene in 2021 has enhanced Apollo's ability to generate insurance premiums, facilitating growth [4] Stock Performance Context - Despite a 19% decline in stock value this year, the strong quarterly results indicate positive progress for Apollo [5]